Phio Pharmaceuticals (PHIO) Leases (2019 - 2021)
Phio Pharmaceuticals' Leases history spans 5 years, with the latest figure at $313000.0 for Q3 2021.
- For Q3 2021, Leases fell 26.87% year-over-year to $313000.0; the TTM value through Sep 2021 reached $313000.0, down 26.87%, while the annual FY2020 figure was $400000.0, 21.72% down from the prior year.
- Leases reached $313000.0 in Q3 2021 per PHIO's latest filing, down from $342000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $592000.0 in Q1 2019 to a low of $313000.0 in Q3 2021.
- Average Leases over 3 years is $454545.5, with a median of $456000.0 recorded in 2020.
- Peak YoY movement for Leases: dropped 18.24% in 2020, then decreased 26.87% in 2021.
- A 3-year view of Leases shows it stood at $511000.0 in 2019, then fell by 21.72% to $400000.0 in 2020, then dropped by 21.75% to $313000.0 in 2021.
- Per Business Quant, the three most recent readings for PHIO's Leases are $313000.0 (Q3 2021), $342000.0 (Q2 2021), and $371000.0 (Q1 2021).